• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Annexon Inc (NQ: ANNX )

    5.200 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 5.200
    Bid (Size) 4.580 (1)
    Ask (Size) 5.950 (4)
    Prev. Close 5.200
    Today's Range 5.200 - 5.200
    52wk Range 1.570 - 8.400
    Shares Outstanding 47,722,995
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire

    Performance

    YTD
    +7.44%
    +7.44%
    1 Month
    +8.33%
    +8.33%
    3 Month
    -14.61%
    -14.61%
    6 Month
    +39.41%
    +39.41%
    1 Year
    +45.25%
    +45.25%

    More News

    Read More
    Annexon Announces Pricing of $125 Million Underwritten Public Offering
    From Annexon Biosciences
    Via GlobeNewswire
    ANNX Stock Earnings: Annexon Beats EPS for Q1 2024
    Via InvestorPlace
    DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Annexon Announces Proposed Public Offering of Common Stock
    From Annexon Biosciences
    Via GlobeNewswire
    Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Mid-Cap Firm Annexon's Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study
    Via Benzinga
    Gold Down 1%; Bath & Body Works Shares Tumble After Q1 Results
    Via Benzinga
    Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
    From Annexon Biosciences
    Via GlobeNewswire
    Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Biosciences to Present at the Bank of America Health Care Conference
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Turnstone Biologics Appoints William Waddill to its Board of Directors
    From Turnstone Biologics Corp.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.